M Sea Pharmaceuticals

Manufacturing of pharmaceutical formulations and related services in India.

About M Sea Pharmaceuticals

M Sea Pharmaceuticals is an Industrial Goods & Manufacturing company. Manufacturing of pharmaceutical formulations and related services in India. It operates in the Industrial Goods & Manufacturing and Healthcare sectors. Its Indian entity M Sea Pharmaceuticals Private Limited reported revenue of β‚Ή13.67 Cr. M Sea Pharmaceuticals offers products and services including Capsules and Dry Syrup. Its focus areas include Contract Manufacturing, Third Party Services, Outsourcing and Pharmaceuticals.

Company details

M Sea Pharmaceuticals Pvt. Ltd. is recognized as a pharmaceutical manufacturer based in India, certified with ISO 9001-2015, GLP, and WHO GMP standards. It is engaged in producing formulations such as tablets, capsules, dry syrups, and oral liquids, with facilities designed to comply with international manufacturing norms. A commitment to quality and safety is upheld, ensuring formulations meet regulatory guidelines. Services include contract and third-party manufacturing for Beta Lactum products, supporting business alliances in the sector. This approach is maintained to deliver reliable therapeutic options.

  • Sectors
    Industrial Goods & Manufacturing
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website mseapharma.com
  • Legal Name M Sea Pharmaceuticals Pvt. Ltd
  • Date of Incorporation 01 Apr, 2015
  • Jurisdiction Himachal Pradesh, India
Key Metrics
  • Indian entity revenue
    ₹13.67 Cr

    FY 2024 · -3% YoY

  • Indian entity net profit
    ₹17.8 Lakh

    FY 2024 · 1% margin

  • Indian entity EBITDA
    ₹1.18 Cr

    FY 2024 · 9% margin

Products & Services of M Sea Pharmaceuticals

M Sea Pharmaceuticals offers a comprehensive portfolio of products and services, including Capsules and Dry Syrup.

Capsules
Pharmaceutical Products

Capsules are produced for both Beta Lactum and non-Beta Lactum uses as part of the pharmaceutical formulations offered.

Dry Syrup
Pharmaceutical Products

Dry syrup formulations are manufactured for Beta Lactum products to ensure they meet required therapeutic standards.

Board of directors of M Sea Pharmaceuticals Private Limited (M Sea Pharmaceuticals)

M Sea Pharmaceuticals Private Limited is the primary company behind M Sea Pharmaceuticals. The board of M Sea Pharmaceuticals Private Limited currently have 6 directors; the longest-serving is Krishnamoorthy Chandru, appointed in 2015. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Krishnamoorthy Chandru
DIN 00893481
Director01 Apr 201511 yrs 7 moM Sea Pharmaceuticals Private Limited
Selvaraj Santha Kumar
DIN 01494954
Director19 Nov 201510 yrs 11 moM Sea Pharmaceuticals Private Limited
Harinath Harinath
DIN 01514762
Director19 Nov 201510 yrs 11 moM Sea Pharmaceuticals Private Limited
Shailender Kumar
DIN 07595696
Director31 Mar 20179 yrs 7 moM Sea Pharmaceuticals Private Limited
Ajay Agarwal
DIN 00728582
Director22 Feb 20188 yrs 8 moM Sea Pharmaceuticals Private Limited
Manish Agarwal
DIN 08279133
Director13 Nov 20188 yrsM Sea Pharmaceuticals Private Limited

Financials of M Sea Pharmaceuticals

Figures of M Sea Pharmaceuticals Private Limited, the primary company behind M Sea Pharmaceuticals, for FY 2024. Revenue was ₹13.67 Cr (-3% year on year). Net profit was ₹17.8 Lakh (1% margin). EBITDA was ₹1.18 Cr (9% margin). Revenue has grown at a compounded annual rate of +8% over three years and +12% over five years.

  • ₹13.67 CrRevenue · FY 2024 · -3% YoY
  • ₹17.8 LakhNet profit · 1% margin
  • ₹1.18 CrEBITDA · 9% margin
  • ₹1.97 CrPaid-up capital
  • 43Employees (provident fund records)
  • +8%Revenue CAGR, 3 years
  • +12%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of M Sea Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for M Sea Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about M Sea Pharmaceuticals

The primary company behind M Sea Pharmaceuticals, M Sea Pharmaceuticals Private Limited, reported revenue of β‚Ή13.67 Cr for FY 2024, down 3% year on year.

M Sea Pharmaceuticals Pvt. Ltd. is recognized as a pharmaceutical manufacturer based in India, certified with ISO 9001-2015, GLP, and WHO GMP standards. It is engaged in producing formulations such as tablets, capsules, dry syrups, and oral liquids, with facilities designed to comply with international manufacturing norms. A commitment to quality and safety is upheld, ensuring formulations meet regulatory guidelines. Services include contract and third-party manufacturing for Beta Lactum products, supporting business alliances in the sector. This approach is maintained to deliver reliable therapeutic options.

M Sea Pharmaceuticals offers Capsules and Dry Syrup.

M Sea Pharmaceuticals operates through M Sea Pharmaceuticals Private Limited.

The legal entities of M Sea Pharmaceuticals currently have 6 directors, including Manish Agarwal, Shailender Kumar, Selvaraj Santha Kumar and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available